GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-021889 |
|---|---|
| Form Type | 4 |
| Filing Date | May 18, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
86,040
Total Value
$216,282.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | May 14, 2026 | Exercise/Conversion | 15,580 | $0.75 | $11,685.00 | 715,580 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 14, 2026 | Sale | 15,580 | $6.91 | $107,657.80 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 15, 2026 | Exercise/Conversion | 13,100 | $0.75 | $9,825.00 | 713,100 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | May 15, 2026 | Sale | 13,100 | $6.65 | $87,115.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 14, 2026 | Exercise/Conversion | 15,580 | $0.00 | $0.00 | 949,535 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | May 15, 2026 | Exercise/Conversion | 13,100 | $0.00 | $0.00 | 936,435 | Direct | โ | View Details |